As of 2025-06-24, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 512.72 USD. This relative valuation is based on P/E multiples. With the latest stock price at 511.92 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 0.2%.
The range of the Relative Valuation is 485.89 - 544.93 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 12.7x | 12.3x |
| Forward P/E multiples | 12.3x - 13.6x | 12.8x |
| Fair Price | 485.89 - 544.93 | 512.72 |
| Upside | -5.1% - 6.4% | 0.2% |
| Date | P/E |
| 2025-06-23 | 12.28 |
| 2025-06-20 | 12.23 |
| 2025-06-18 | 12.32 |
| 2025-06-17 | 12.21 |
| 2025-06-16 | 12.54 |
| 2025-06-13 | 12.70 |
| 2025-06-12 | 12.52 |
| 2025-06-11 | 12.44 |
| 2025-06-10 | 12.56 |
| 2025-06-09 | 12.42 |
| 2025-06-06 | 11.84 |
| 2025-06-05 | 11.59 |
| 2025-06-04 | 11.64 |
| 2025-06-03 | 11.71 |
| 2025-06-02 | 11.78 |
| 2025-05-30 | 11.77 |
| 2025-05-29 | 14.53 |
| 2025-05-28 | 14.20 |
| 2025-05-27 | 14.48 |
| 2025-05-23 | 14.12 |
| 2025-05-22 | 14.32 |
| 2025-05-21 | 14.51 |
| 2025-05-20 | 14.75 |
| 2025-05-19 | 14.32 |
| 2025-05-16 | 14.26 |
| 2025-05-15 | 14.04 |
| 2025-05-14 | 13.71 |
| 2025-05-13 | 13.78 |
| 2025-05-12 | 13.81 |
| 2025-05-09 | 12.67 |
| 2025-05-08 | 13.14 |
| 2025-05-07 | 13.46 |
| 2025-05-06 | 13.40 |
| 2025-05-05 | 14.48 |
| 2025-05-02 | 14.53 |
| 2025-05-01 | 14.16 |
| 2025-04-30 | 14.37 |
| 2025-04-29 | 13.65 |
| 2025-04-28 | 14.66 |
| 2025-04-25 | 14.46 |
| 2025-04-24 | 14.39 |
| 2025-04-23 | 14.11 |
| 2025-04-22 | 14.05 |
| 2025-04-21 | 13.47 |
| 2025-04-17 | 13.51 |
| 2025-04-16 | 13.18 |
| 2025-04-15 | 13.39 |
| 2025-04-14 | 13.70 |
| 2025-04-11 | 13.30 |
| 2025-04-10 | 13.11 |